Clinical Trial Update: Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports results for metreleptin therapy in treating severe insulin resistance. Results were posted on 2021-12-15.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• Metreleptin (metreleptin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Severe Insulin Resistance | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-12-15